Where does Celsee Diagnostics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Celsee Diagnostics, Inc. ranks #13,351 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Celsee Diagnostics, Inc. hold?

Celsee Diagnostics, Inc. holds 22 US utility patents granted between 2019 and 2020, spanning 8 technology areas.

What is Celsee Diagnostics, Inc.'s Innovation Score?

Celsee Diagnostics, Inc. has an Innovation Score of 32.5 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Celsee Diagnostics, Inc. focus on?

Celsee Diagnostics, Inc.'s top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 21 patents, ranking #89 of 1,325 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Celsee Diagnostics, Inc.'s patent grant rate increasing or decreasing?

Celsee Diagnostics, Inc.'s recent grant velocity is -62% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Celsee Diagnostics, Inc.'s patents?

Celsee Diagnostics, Inc.'s patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Celsee Diagnostics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Celsee Diagnostics, Inc.

USPTO PatentsView assignee record - 22 granted patents across 8 technology areas, recorded in grant years 2019–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Celsee ranks #13,351 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 8 technology areas.

#13,351
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.5/100): 19.4
avg claims per patent: -62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13351 · US Corporation #13,351 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,351/49,997
PHOTO-FINISH Carbon Black
CPC-NARROW B01L · 8 areas
INNOV-THIN 32.5/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -62% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Carbon Black, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Celsee’s 32.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (33%) Velocity 0.0 pts (0%) Breadth 10.0 pts (31%) Claim depth 11.6 pts (36%)

Qualcomm Incorporated · highest

85
Celsee Diagnostics · this assignee

32
3D Lighting… · lowest

7

What this shows Celsee's Innovation Score is 32.5/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Celsee?

Each dot is one of Celsee’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Celsee’s own 19.4 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Celsee vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Celsee's grants concentrate

Celsee Diagnostics, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 95.5% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2019 (16 grants) versus a trough of 6 in 2020. By volume, Celsee sits between Carbon Black, Inc. and Clarify Health Solutions, Inc..

Carbon Black

22
Cardiac Implants

22
Carl Zeiss Vision

22
Carmel Pharma AB

22
Cerevasc

22
Chongqing Ruzer P…

22
Clariant Plastics…

22
Clarify Health So…

22
Celsee Diagnostics ◀

22

What this shows Celsee holds 22 patents at rank #13,363, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Celsee

By rank, the assignees closest to #13,363 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Celsee's primary technology class.

Celsee's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Celsee Diagnostics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	16	72.7%
2020	6	27.3%

Which technologies does Celsee Diagnostics, Inc. patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 21

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 21

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 19

G06V - Image OR Video Recognition OR Understanding 13

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

G02B - Optical Elements, Systems OR Apparatus 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Celsee Diagnostics, Inc.'s patent record in context - here's where to go next.

Celsee Diagnostics, Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 95.5% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #13,351 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Celsee Diagnostics, Inc. against Carbon Black, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.